Onkure Therapeutics Inc. Class AOKUR
13F holders, Q4 2025 (December 31)At the end of Q4 2025, 43 institutions reported holding Onkure Therapeutics Inc. Class A (OKUR) in their 13F filings, up 1 from Q3 2025. 6 opened new positions and 6 sold out. The largest holders were Acorn Capital Advisors, LLC ($8.2M), ADAR1 Capital Management, LLC ($2.9M) and Prosight Management, LP ($2.4M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Onkure Therapeutics Inc. Class A
- CUSIP
- 68277Q105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $5.2M |
| Exits | 6 | $334K |
All 13F filers, Q3 2025 → Q4 2025: 2,460,144 shares bought and 1,821,902 shares sold, net +638,242 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 43 holders
| Acorn Capital Advisors, LLC | 2.79% | No change | 2,839,674 | $8.2M |
| ADAR1 Capital Management, LLC | 0.22% | New | 1,014,158 | $2.9M |
| Prosight Management, LP | 0.49% | Add +204.9% | 816,909 | $2.4M |
| Shay Capital LLC | 0.37% | Reduce -14.9% | 780,861 | $2.3M |
| Rosalind Advisors, Inc. | 0.77% | New | 730,488 | $2.1M |
| Vestal Point Capital, LP | 0.07% | No change | 635,000 | $1.8M |
| Vanguard Group Inc. | 0.00% | Reduce -7.6% | 626,593 | $1.8M |
| Highbridge Capital Management LLC | 0.12% | Reduce -16.6% | 542,361 | $1.6M |
| NEA Management Company, LLC | 0.07% | No change | 478,548 | $1.4M |
| StepStone Group LP | 0.73% | No change | 491,938 | $1.4M |
| Cantor Fitzgerald, L. P. | 0.04% | Reduce -9.5% | 445,078 | $1.3M |
| Carlyle Group Inc. | 0.01% | No change | 269,895 | $772K |
| Renaissance Technologies | 0.00% | Add +40.7% | 247,350 | $717K |
| Citadel Advisors | 0.00% | Reduce -78.0% | 223,125 | $647K |
| Kotler Kevin | 0.42% | — | 197,691 | $573K |
| Rangeley Capital, LLC | 0.37% | Reduce -6.8% | 145,000 | $421K |
| Aisling Capital Management LP | 0.05% | No change | 88,607 | $257K |
| Geode Capital Management, LLC | 0.00% | Reduce -8.8% | 77,469 | $225K |
| Sphera Funds Management LTD. | 0.04% | No change | 60,454 | $175K |
| BlackRock, Inc. | 0.00% | Reduce -90.7% | 52,678 | $153K |
| Gsa Capital Partners LLP | 0.01% | Reduce -22.4% | 45,948 | $133K |
| Aldebaran Capital, LLC | 0.11% | Reduce -6.2% | 41,284 | $120K |
| Barclays PLC | 0.00% | Add +4286.8% | 27,242 | $79K |
| Two Sigma Advisers, LP | 0.00% | No change | 26,608 | $77K |
| Morgan Stanley | 0.00% | Add +45.0% | 24,962 | $72K |
| HSBC Holdings PLC | 0.00% | New | 19,973 | $58K |
| Northern Trust Corp. | 0.00% | Reduce -11.6% | 19,903 | $58K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 19,500 | $57K |
| Jane Street Group, LLC | 0.00% | New | 19,414 | $56K |
| XTX Topco Ltd | 0.00% | New | 17,801 | $52K |
| Two Sigma Investments, LP | 0.00% | Reduce -55.5% | 11,320 | $33K |
| Wells Fargo & Company | 0.00% | Add +15.8% | 11,000 | $32K |
| Citigroup Inc. | 0.00% | Add +12.2% | 3,729 | $11K |
| UBS Group AG | 0.00% | Add +489.3% | 1,208 | $4K |
| JPMorgan Chase & Co. | 0.00% | Add +28.8% | 545 | $2K |
| FMR LLC | 0.00% | Add +700.0% | 400 | $1K |
| BNP Paribas Financial Markets | 0.00% | Reduce -22.8% | 281 | $815 |
| Bank of America Corp. | 0.00% | Reduce -84.3% | 141 | $409 |
| Trust Co. of Toledo NA | 0.00% | No change | 136 | $394 |
| Osaic Holdings, Inc. | 0.00% | Add +9.0% | 109 | $316 |
| Group One Trading LLC | 0.00% | No change | 56 | $162 |
| Northwestern Mutual Wealth Management Co. | 0.00% | New | 2 | $6 |
| Royal Bank of Canada | 0.00% | Reduce -46.3% | 102 | $0 |
"% of holder's portfolio" is OKUR's weight in each manager's 13F, not the share of Onkure Therapeutics Inc. Class A the manager owns.